GlassScriptPhysician profile
Alec Bonifer
NPI 1407483167
$4,517.17
in general payments reported to CMS, 2019-2025
7 companies · $2,743 in 2025
The $2,743 reported for 2025 was more than what 93% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
See the full distribution for Plastic Surgery within the Head & Neck
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $200 · 2024: $1,443 · 2025: $2,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,684 · Food and Beverage: $1,701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,684.22 |
| Food and Beverage | $1,701.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $3,689.33 | 2024-2025 | Inspire |
| Stryker Corporation | $387.69 | 2022-2025 | Scopis Ent, Latera, Clarifix Cryotherapy Device |
| Aroa Biosurgery Incorporated | $141.36 | 2025 | |
| Baxter Healthcare | $138.03 | 2025 | Tisseel |
| Medtronic, INC. | $111.59 | 2022-2025 | Cd Horizon Spinal System, Fusion |
| Polynovo North America LLC | $28.58 | 2025 | Novosorb Btm |
| Merck Sharp & Dohme LLC | $20.59 | 2023 | Keytruda, Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alec Bonifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.